내당능검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 적응 질환별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Glucose Tolerance Test Market Size, Share, Growth Analysis, By Product Type (Smart Sensors, Blood Glucose Testing Kit), By Disease Indication (Reactive Hypoglycemia, Diabetes Hypoglycemia), By End user, By Region - Industry Forecast 2025-2032
상품코드:1630660
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 213 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 내당능검사 시장 규모는 2023년에 272억 달러로 평가되며, 2024년 288억 달러에서 2032년에는 455억 7,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 5.9%로 성장할 전망입니다.
당뇨병 케어 시장은 당뇨병 유병률 증가, 기술 발전, 현장 혈당 검사(POC)의 장점에 대한 인식이 높아지면서 괄목할 만한 성장을 거듭하고 있습니다. 비침습적 혈당 모니터링 기기의 도입은 당뇨병 관리에 혁명을 일으켜 환자들에게 고통 없는 선택권을 제공하고 있으며, Clinical &Laboratories Standard Institute의 최근 정확도 가이드라인 표준화는 특히 중환자실 환경에서 POC 검사의 신뢰성을 강화하고 있습니다. 2021년에는 5억 3,700만 명의 당뇨병 환자가 있을 것으로 예상되며, 2045년에는 7억 8,300만 명에 달할 것으로 예상됩니다. 혈당 진단 및 단시간 검사(STAT) 솔루션에 대한 수요 증가는 혈당 수치 관리에서 환자 관리, 효율성 및 컴플라이언스 개선에 중점을 두고 있는 헬스케어 부문의 태도를 반영하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
내당능검사 시장 규모 : 제품 유형별
시장 개요
스마트 센서
혈당치 검사 키트
미터
테스트 스트립
기타
내당능검사 시장 규모 : 질환 적응증별
시장 개요
반응성저혈당
당뇨병저혈당
임신 당뇨병
인슐린 저항성
기타
내당능검사 시장 규모 : 최종사용자별
시장 개요
병원
클리닉
진단 센터
기타
내당능검사 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Thermo Fisher Scientific Inc.(United States)
Medtronic(United States)
NIPRO(Japan)
Trividia Health, Inc.(United States)
Dexcom, Inc.(United States)
Healius Limited(Australia)
Penlan Healthcare Ltd.(United Kingdom)
Quest Diagnostics Incorporated(United States)
Johnson & Johnson Services, Inc.(United States)
Abbott(United States)
Laboratory Corporation of America Holdings(United States)
ARUP Laboratories(United States)
Cleveland HeartLab, Inc.(United States)
Merck KGaA(Germany)
Bayer AG(Germany)
Ascensia Diabetes Care Holdings AG(Switzerland)
E-Zlab Health Services(Canada)
F. Hoffman-La Roche Ltd(Switzerland)
LifeScan IP Holdings, LLC(United States)
Sanofi(France)
결론과 권장사항
KSA
영문 목차
영문목차
Global Glucose Tolerance Test Market size was valued at USD 27.2 billion in 2023 and is poised to grow from USD 28.8 billion in 2024 to USD 45.57 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).
The market for diabetes care is experiencing significant growth, driven by increasing diabetes prevalence, technological advancements, and heightened awareness of point-of-care (POC) glucose testing benefits. The introduction of needle-free blood glucose monitoring devices is revolutionizing diabetes management, offering patients a painless alternative. Recent standardization of accuracy guidelines by the Clinical & Laboratories Standard Institute bolsters the reliability of POC testing, especially in critical care environments. With an estimated 537 million people living with diabetes in 2021, forecast projections suggest this number could reach 783 million by 2045. The rising demand for glucose diagnostics and Short Turn-Around Testing (STAT) solutions reflects the healthcare sector's focus on improved patient care, efficiency, and compliance in managing glucose levels.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glucose Tolerance Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Glucose Tolerance Test Market Segmental Analysis
Global Glucose Tolerance Test Market is segmented by Product Type, Disease Indication, End user and region. Based on Product Type, the market is segmented into Smart Sensors, Blood Glucose Testing Kit, Meters, Test Slips and Others. Based on Disease Indication, the market is segmented into Reactive Hypoglycemia, Diabetes Hypoglycemia, Gestational Diabetes, Insulin Resistance and Others. Based on End user, the market is segmented into Hospitals, Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Glucose Tolerance Test Market
The global glucose tolerance test market is significantly driven by the escalating prevalence of diabetes across the globe. Factors contributing to this alarming rise include lifestyle alterations, such as decreased physical activity and unhealthy dietary choices, which in turn amplify the demand for reliable diagnostic tools like glucose tolerance tests. As the awareness surrounding diabetes continues to grow, so does the popularity of these tests, owing to their essential role in the early detection and management of the condition. Consequently, the increasing diabetes rates are compelling healthcare providers and patients alike to prioritize the utilization of glucose tolerance testing, propelling the market forward.
Restraints in the Global Glucose Tolerance Test Market
The global glucose tolerance test market faces significant constraints primarily due to the high costs associated with testing. Many individuals, particularly in economically disadvantaged regions, find these expenses prohibitive, which can lead to a reluctance to undergo essential diagnostic procedures. The financial burden stems from the prices of glucose testing kits, meters, and necessary accessories, along with the frequency of testing required to monitor glucose levels effectively. This situation may hinder market growth by discouraging patients from seeking vital testing services, ultimately affecting overall public health and the early detection of diabetes and related conditions.
Market Trends of the Global Glucose Tolerance Test Market
The Global Glucose Tolerance Test (GTT) market is experiencing significant growth due to advancing diagnostic technologies and increasing diabetes prevalence. As global populations age and unhealthy lifestyle choices rise, there is a marked increase in cases of diabetes and prediabetes, driving the demand for accurate diagnostic tools. Healthcare policies are also evolving to prioritize early intervention, highlighting the necessity for effective screening methods like the GTT. This burgeoning market is fueled by continual innovations in testing methodologies and an urgent need for reliable diagnostics, positioning GTT as a critical component in diabetes management strategies worldwide.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Glucose Tolerance Test Market Size by Product Type & CAGR (2025-2032)
Market Overview
Smart Sensors
Blood Glucose Testing Kit
Meters
Test Slips
Others
Global Glucose Tolerance Test Market Size by Disease Indication & CAGR (2025-2032)
Market Overview
Reactive Hypoglycemia
Diabetes Hypoglycemia
Gestational Diabetes
Insulin Resistance
Others
Global Glucose Tolerance Test Market Size by End user & CAGR (2025-2032)
Market Overview
Hospitals
Clinics
Diagnostic Centers
Others
Global Glucose Tolerance Test Market Size & CAGR (2025-2032)
North America (Product Type, Disease Indication, End user)
US
Canada
Europe (Product Type, Disease Indication, End user)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Disease Indication, End user)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Disease Indication, End user)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Disease Indication, End user)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Thermo Fisher Scientific Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medtronic (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
NIPRO (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Trividia Health, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Dexcom, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Healius Limited (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Penlan Healthcare Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Quest Diagnostics Incorporated (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Johnson & Johnson Services, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Abbott (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Laboratory Corporation of America Holdings (United States)
